1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Epinastine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Tablets 1.2.3 Capsule 1.2.4 Eye Drops 1.3 Market by Application 1.3.1 Global Epinastine Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Conjunctivitis 1.3.3 Allergy 1.3.4 Asthma 1.3.5 Eczema 1.3.6 Perennial Allergic Rhinitis 1.3.7 Seasonal Allergic Rhinitis 1.3.8 Psoriasis 1.3.9 Pruritus 1.3.10 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Epinastine Market Perspective (2016-2027) 2.2 Epinastine Growth Trends by Regions 2.2.1 Epinastine Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Epinastine Historic Market Share by Regions (2016-2021) 2.2.3 Epinastine Forecasted Market Size by Regions (2022-2027) 2.3 Epinastine Industry Dynamic 2.3.1 Epinastine Market Trends 2.3.2 Epinastine Market Drivers 2.3.3 Epinastine Market Challenges 2.3.4 Epinastine Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Epinastine Players by Revenue 3.1.1 Global Top Epinastine Players by Revenue (2016-2021) 3.1.2 Global Epinastine Revenue Market Share by Players (2016-2021) 3.2 Global Epinastine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Epinastine Revenue 3.4 Global Epinastine Market Concentration Ratio 3.4.1 Global Epinastine Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Epinastine Revenue in 2020 3.5 Epinastine Key Players Head office and Area Served 3.6 Key Players Epinastine Product Solution and Service 3.7 Date of Enter into Epinastine Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Epinastine Breakdown Data by Type 4.1 Global Epinastine Historic Market Size by Type (2016-2021) 4.2 Global Epinastine Forecasted Market Size by Type (2022-2027) 5 Epinastine Breakdown Data by Application 5.1 Global Epinastine Historic Market Size by Application (2016-2021) 5.2 Global Epinastine Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Epinastine Market Size (2016-2027) 6.2 North America Epinastine Market Size by Type 6.2.1 North America Epinastine Market Size by Type (2016-2021) 6.2.2 North America Epinastine Market Size by Type (2022-2027) 6.2.3 North America Epinastine Market Size by Type (2016-2027) 6.3 North America Epinastine Market Size by Application 6.3.1 North America Epinastine Market Size by Application (2016-2021) 6.3.2 North America Epinastine Market Size by Application (2022-2027) 6.3.3 North America Epinastine Market Size by Application (2016-2027) 6.4 North America Epinastine Market Size by Country 6.4.1 North America Epinastine Market Size by Country (2016-2021) 6.4.2 North America Epinastine Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Epinastine Market Size (2016-2027) 7.2 Europe Epinastine Market Size by Type 7.2.1 Europe Epinastine Market Size by Type (2016-2021) 7.2.2 Europe Epinastine Market Size by Type (2022-2027) 7.2.3 Europe Epinastine Market Size by Type (2016-2027) 7.3 Europe Epinastine Market Size by Application 7.3.1 Europe Epinastine Market Size by Application (2016-2021) 7.3.2 Europe Epinastine Market Size by Application (2022-2027) 7.3.3 Europe Epinastine Market Size by Application (2016-2027) 7.4 Europe Epinastine Market Size by Country 7.4.1 Europe Epinastine Market Size by Country (2016-2021) 7.4.2 Europe Epinastine Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Epinastine Market Size (2016-2027) 8.2 Asia-Pacific Epinastine Market Size by Type 8.2.1 Asia-Pacific Epinastine Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Epinastine Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Epinastine Market Size by Type (2016-2027) 8.3 Asia-Pacific Epinastine Market Size by Application 8.3.1 Asia-Pacific Epinastine Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Epinastine Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Epinastine Market Size by Application (2016-2027) 8.4 Asia-Pacific Epinastine Market Size by Region 8.4.1 Asia-Pacific Epinastine Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Epinastine Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Epinastine Market Size (2016-2027) 9.2 Latin America Epinastine Market Size by Type 9.2.1 Latin America Epinastine Market Size by Type (2016-2021) 9.2.2 Latin America Epinastine Market Size by Type (2022-2027) 9.2.3 Latin America Epinastine Market Size by Type (2016-2027) 9.3 Latin America Epinastine Market Size by Application 9.3.1 Latin America Epinastine Market Size by Application (2016-2021) 9.3.2 Latin America Epinastine Market Size by Application (2022-2027) 9.3.3 Latin America Epinastine Market Size by Application (2016-2027) 9.4 Latin America Epinastine Market Size by Country 9.4.1 Latin America Epinastine Market Size by Country (2016-2021) 9.4.2 Latin America Epinastine Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Epinastine Market Size (2016-2027) 10.2 Middle East & Africa Epinastine Market Size by Type 10.2.1 Middle East & Africa Epinastine Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Epinastine Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Epinastine Market Size by Type (2016-2027) 10.3 Middle East & Africa Epinastine Market Size by Application 10.3.1 Middle East & Africa Epinastine Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Epinastine Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Epinastine Market Size by Application (2016-2027) 10.4 Middle East & Africa Epinastine Market Size by Country 10.4.1 Middle East & Africa Epinastine Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Epinastine Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Santen 11.1.1 Santen Company Details 11.1.2 Santen Business Overview 11.1.3 Santen Epinastine Introduction 11.1.4 Santen Revenue in Epinastine Business (2016-2021) 11.1.5 Santen Recent Development 11.2 Merck 11.2.1 Merck Company Details 11.2.2 Merck Business Overview 11.2.3 Merck Epinastine Introduction 11.2.4 Merck Revenue in Epinastine Business (2016-2021) 11.2.5 Merck Recent Development 11.3 Daiichi Sankyo 11.3.1 Daiichi Sankyo Company Details 11.3.2 Daiichi Sankyo Business Overview 11.3.3 Daiichi Sankyo Epinastine Introduction 11.3.4 Daiichi Sankyo Revenue in Epinastine Business (2016-2021) 11.3.5 Daiichi Sankyo Recent Development 11.4 Allergan 11.4.1 Allergan Company Details 11.4.2 Allergan Business Overview 11.4.3 Allergan Epinastine Introduction 11.4.4 Allergan Revenue in Epinastine Business (2016-2021) 11.4.5 Allergan Recent Development 11.5 Akorn 11.5.1 Akorn Company Details 11.5.2 Akorn Business Overview 11.5.3 Akorn Epinastine Introduction 11.5.4 Akorn Revenue in Epinastine Business (2016-2021) 11.5.5 Akorn Recent Development 11.6 Amneal Pharmaceuticals 11.6.1 Amneal Pharmaceuticals Company Details 11.6.2 Amneal Pharmaceuticals Business Overview 11.6.3 Amneal Pharmaceuticals Epinastine Introduction 11.6.4 Amneal Pharmaceuticals Revenue in Epinastine Business (2016-2021) 11.6.5 Amneal Pharmaceuticals Recent Development 11.7 Apotex Corp 11.7.1 Apotex Corp Company Details 11.7.2 Apotex Corp Business Overview 11.7.3 Apotex Corp Epinastine Introduction 11.7.4 Apotex Corp Revenue in Epinastine Business (2016-2021) 11.7.5 Apotex Corp Recent Development 11.8 Cypress Pharmaceuticals 11.8.1 Cypress Pharmaceuticals Company Details 11.8.2 Cypress Pharmaceuticals Business Overview 11.8.3 Cypress Pharmaceuticals Epinastine Introduction 11.8.4 Cypress Pharmaceuticals Revenue in Epinastine Business (2016-2021) 11.8.5 Cypress Pharmaceuticals Recent Development 11.9 Boehringer Ingelheim 11.9.1 Boehringer Ingelheim Company Details 11.9.2 Boehringer Ingelheim Business Overview 11.9.3 Boehringer Ingelheim Epinastine Introduction 11.9.4 Boehringer Ingelheim Revenue in Epinastine Business (2016-2021) 11.9.5 Boehringer Ingelheim Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Epinastine Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Tablets Table 3. Key Players of Capsule Table 4. Key Players of Eye Drops Table 5. Global Epinastine Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Epinastine Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Epinastine Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Epinastine Market Share by Regions (2016-2021) Table 9. Global Epinastine Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Epinastine Market Share by Regions (2022-2027) Table 11. Epinastine Market Trends Table 12. Epinastine Market Drivers Table 13. Epinastine Market Challenges Table 14. Epinastine Market Restraints Table 15. Global Epinastine Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Epinastine Market Share by Players (2016-2021) Table 17. Global Top Epinastine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epinastine as of 2020) Table 18. Ranking of Global Top Epinastine Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Epinastine Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Epinastine Product Solution and Service Table 22. Date of Enter into Epinastine Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Epinastine Market Size by Type (2016-2021) (US$ Million) Table 25. Global Epinastine Revenue Market Share by Type (2016-2021) Table 26. Global Epinastine Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global Epinastine Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global Epinastine Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global Epinastine Revenue Market Share by Application (2016-2021) Table 30. Global Epinastine Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global Epinastine Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America Epinastine Market Size by Type (2016-2021) (US$ Million) Table 33. North America Epinastine Market Size by Type (2022-2027) & (US$ Million) Table 34. North America Epinastine Market Size by Application (2016-2021) (US$ Million) Table 35. North America Epinastine Market Size by Application (2022-2027) & (US$ Million) Table 36. North America Epinastine Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Epinastine Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Epinastine Market Size by Type (2016-2021) (US$ Million) Table 39. Europe Epinastine Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe Epinastine Market Size by Application (2016-2021) (US$ Million) Table 41. Europe Epinastine Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe Epinastine Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Epinastine Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Epinastine Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific Epinastine Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific Epinastine Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific Epinastine Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific Epinastine Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Epinastine Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Epinastine Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America Epinastine Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America Epinastine Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America Epinastine Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America Epinastine Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Epinastine Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Epinastine Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa Epinastine Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa Epinastine Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa Epinastine Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa Epinastine Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa Epinastine Market Size by Country (2022-2027) & (US$ Million) Table 62. Santen Company Details Table 63. Santen Business Overview Table 64. Santen Epinastine Product Table 65. Santen Revenue in Epinastine Business (2016-2021) & (US$ Million) Table 66. Santen Recent Development Table 67. Merck Company Details Table 68. Merck Business Overview Table 69. Merck Epinastine Product Table 70. Merck Revenue in Epinastine Business (2016-2021) & (US$ Million) Table 71. Merck Recent Development Table 72. Daiichi Sankyo Company Details Table 73. Daiichi Sankyo Business Overview Table 74. Daiichi Sankyo Epinastine Product Table 75. Daiichi Sankyo Revenue in Epinastine Business (2016-2021) & (US$ Million) Table 76. Daiichi Sankyo Recent Development Table 77. Allergan Company Details Table 78. Allergan Business Overview Table 79. Allergan Epinastine Product Table 80. Allergan Revenue in Epinastine Business (2016-2021) & (US$ Million) Table 81. Allergan Recent Development Table 82. Akorn Company Details Table 83. Akorn Business Overview Table 84. Akorn Epinastine Product Table 85. Akorn Revenue in Epinastine Business (2016-2021) & (US$ Million) Table 86. Akorn Recent Development Table 87. Amneal Pharmaceuticals Company Details Table 88. Amneal Pharmaceuticals Business Overview Table 89. Amneal Pharmaceuticals Epinastine Product Table 90. Amneal Pharmaceuticals Revenue in Epinastine Business (2016-2021) & (US$ Million) Table 91. Amneal Pharmaceuticals Recent Development Table 92. Apotex Corp Company Details Table 93. Apotex Corp Business Overview Table 94. Apotex Corp Epinastine Product Table 95. Apotex Corp Revenue in Epinastine Business (2016-2021) & (US$ Million) Table 96. Apotex Corp Recent Development Table 97. Cypress Pharmaceuticals Company Details Table 98. Cypress Pharmaceuticals Business Overview Table 99. Cypress Pharmaceuticals Revenue in Epinastine Business (2016-2021) & (US$ Million) Table 100. Cypress Pharmaceuticals Recent Development Table 101. Boehringer Ingelheim Company Details Table 102. Boehringer Ingelheim Business Overview Table 103. Boehringer Ingelheim Epinastine Product Table 104. Boehringer Ingelheim Revenue in Epinastine Business (2016-2021) & (US$ Million) Table 105. Boehringer Ingelheim Recent Development Table 106. Research Programs/Design for This Report Table 107. Key Data Information from Secondary Sources Table 108. Key Data Information from Primary Sources List of Figures Figure 1. Global Epinastine Market Share by Type: 2020 VS 2027 Figure 2. Tablets Features Figure 3. Capsule Features Figure 4. Eye Drops Features Figure 5. Global Epinastine Market Share by Application: 2020 VS 2027 Figure 6. Conjunctivitis Case Studies Figure 7. Allergy Case Studies Figure 8. Asthma Case Studies Figure 9. Eczema Case Studies Figure 10. Perennial Allergic Rhinitis Case Studies Figure 11. Seasonal Allergic Rhinitis Case Studies Figure 12. Psoriasis Case Studies Figure 13. Pruritus Case Studies Figure 14. Others Case Studies Figure 15. Epinastine Report Years Considered Figure 16. Global Epinastine Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 17. Global Epinastine Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 18. Global Epinastine Market Share by Regions: 2020 VS 2027 Figure 19. Global Epinastine Market Share by Regions (2022-2027) Figure 20. Global Epinastine Market Share by Players in 2020 Figure 21. Global Top Epinastine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epinastine as of 2020 Figure 22. The Top 10 and 5 Players Market Share by Epinastine Revenue in 2020 Figure 23. Global Epinastine Revenue Market Share by Type (2016-2021) Figure 24. Global Epinastine Revenue Market Share by Type (2022-2027) Figure 25. North America Epinastine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. North America Epinastine Market Share by Type (2016-2027) Figure 27. North America Epinastine Market Share by Application (2016-2027) Figure 28. North America Epinastine Market Share by Country (2016-2027) Figure 29. United States Epinastine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. Canada Epinastine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Europe Epinastine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Europe Epinastine Market Share by Type (2016-2027) Figure 33. Europe Epinastine Market Share by Application (2016-2027) Figure 34. Europe Epinastine Market Share by Country (2016-2027) Figure 35. Germany Epinastine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. France Epinastine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. U.K. Epinastine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Italy Epinastine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Russia Epinastine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Nordic Epinastine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Asia-Pacific Epinastine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Asia-Pacific Epinastine Market Share by Type (2016-2027) Figure 43. Asia-Pacific Epinastine Market Share by Application (2016-2027) Figure 44. Asia-Pacific Epinastine Market Share by Region (2016-2027) Figure 45. China Epinastine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Japan Epinastine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. South Korea Epinastine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Southeast Asia Epinastine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. India Epinastine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Australia Epinastine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Latin America Epinastine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Latin America Epinastine Market Share by Type (2016-2027) Figure 53. Latin America Epinastine Market Share by Application (2016-2027) Figure 54. Latin America Epinastine Market Share by Country (2016-2027) Figure 55. Mexico Epinastine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Brazil Epinastine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Middle East & Africa Epinastine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Middle East & Africa Epinastine Market Share by Type (2016-2027) Figure 59. Middle East & Africa Epinastine Market Share by Application (2016-2027) Figure 60. Middle East & Africa Epinastine Market Share by Country (2016-2027) Figure 61. Turkey Epinastine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 62. Saudi Arabia Epinastine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 63. UAE Epinastine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 64. Santen Revenue Growth Rate in Epinastine Business (2016-2021) Figure 65. Merck Revenue Growth Rate in Epinastine Business (2016-2021) Figure 66. Daiichi Sankyo Revenue Growth Rate in Epinastine Business (2016-2021) Figure 67. Allergan Revenue Growth Rate in Epinastine Business (2016-2021) Figure 68. Akorn Revenue Growth Rate in Epinastine Business (2016-2021) Figure 69. Amneal Pharmaceuticals Revenue Growth Rate in Epinastine Business (2016-2021) Figure 70. Apotex Corp Revenue Growth Rate in Epinastine Business (2016-2021) Figure 71. Cypress Pharmaceuticals Revenue Growth Rate in Epinastine Business (2016-2021) Figure 72. Boehringer Ingelheim Revenue Growth Rate in Epinastine Business (2016-2021) Figure 73. Bottom-up and Top-down Approaches for This Report Figure 74. Data Triangulation Figure 75. Key Executives Interviewed

Santen Merck Daiichi Sankyo Allergan Akorn Amneal Pharmaceuticals Apotex Corp Cypress Pharmaceuticals Boehringer Ingelheim